Crossmark

Infliximab microencapsulation: an innovative approach for intra-articular administration of biologics in the management of rheumatoid arthritis—in vitro evaluation

Crossref DOI link: https://doi.org/10.1007/s13346-023-01372-1

Published Online: 2023-06-09

Published Print: 2023-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lamela-Gómez, Iván https://orcid.org/0000-0002-1339-3101
Gonçalves, Lídia M. https://orcid.org/0000-0002-6799-2740
Almeida, António J. https://orcid.org/0000-0002-7807-4726
Luzardo-Álvarez, Asteria https://orcid.org/0000-0002-8842-0960
Funding

Funding for this research was provided by:

Consellería de Cultura, Educación e Ordenación Universitaria, Xunta de Galicia (Predoctoral Grant Program. DOG Núm. 151. (2017/08/09))

Consellería de Cultura, Educación e Ordenación Universitaria, Xunta de Galicia (ED341C 2017/13)

Fundação para a Ciência e a Tecnologia (UID/DTP/04138/2019 and UIDB/04138/2020)

Fundação para a Ciência e a Tecnologia (CEECIND/03143/2017)

Universidade de Santiago de Compostela
License Information

Text and Data Mining valid from 2023-06-09

Version of Record valid from 2023-06-09
More Information

Article History

Accepted: 20 May 2023

First Online: 9 June 2023

Declarations

:

: Not applicable. No animal or human studies were carried out by the authors for this article.

: Not applicable. No human studies were carried out by the authors for this article.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below